Published on May 31, 2016 At Roche Pharma Research and Early Development, we are working on a novel form of engineered antibodies for cancer immunotherapy that we call T-cell bispecific antibodies. We consider them match-makers between T-Cells and cancer cells. With two handles, they recognize specific markers on the surface of cancer cells. A third handle is designed to hook …
Sweden’s strong tradition in genetic technologyView Post
Pharmacogenetics the Dutch wayView Post
We need to change our expectationsView Post
Link via Dana-Farber Cancer Institute How does immunotherapy fight cancer? If you take the brakes off the immune system, you can unleash an attack on cancer cells. That’s the theory behind PD-1/PD-L1, a vitally important immunotherapy discovery illustrated in this video.
Link via Winship Cancer Institute of Emory University Understanding cancer cell behavior is a fundamental step toward advancing precision medicine. Winship’s Adam Marcus, PhD, shows how his lab is isolating and studying the behavior “leader” cells that may be the key to cancer metastasis.
On the one year anniversary of the launch of the Precision Medicine Initiative, President Obama participates in a panel discussion moderated by Dr. James Hamblin of The Atlantic on the importance of PMI in South Court Auditorium at the White House, February 25, 2016. “Doctors have always recognized that every patient is unique, and doctors have always tried to tailor …
Watch this Newfoundlanders story about how genomics is offering him protection against a potentially lethal disease.
Precision medicine aims to collect, connect, and apply vast amounts of data and information about our health to help guide more precise and predictive medicine worldwide. Learn more at http://precisionmedicine.ucsf.edu/
Precision medicine is the practice of using a cancer cell’s DNA to guide therapy. Learn how scientists have used precision medicine to treat rare brain tumors. This video was produced in collaboration with Malak Abed and her team in Boston.
Published on Nov 4, 2015 In a study published in Nature Communications, Dr. Muhammed Murtaza, who holds a joint appointment at Mayo Clinic and Translational Genomics Research Institute (TGEN), and colleagues, describe an extensive comparison between biopsy results and analysis of ctDNA in a patient with breast cancer. In the following video, Dr. Murtaza describes how circulating tumor DNA in …
Since the discovery of DNA’s fundamental role in building and sustaining life, scientists have dreamed of having the ability to easily edit DNA in very precise ways. This video explores how a group of scientists made a major breakthrough in understanding the bacterial immune response, called the CRISPR/Cas system, and discovered a way to utilize this system to create a …
- Page 2 of 2